![Michael Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Gold
Technik-/Wissenschafts-/F&E-Leiter bei
COMPASS PATHWAYS PLC
Profil
Michael Gold is currently the Chief Research & Development Officer at Compass Pathways Plc.
Previously, he worked as the Medical Director-Memory Disorder Clinic at the University of South Florida.
From 2017 to 2023, he served as the Vice President at AbbVie, Inc. In 2011 to 2013, he held the position of Chief Medical Officer at Allon Therapeutics, Inc. Additionally, from 2023 to 2024, he was the Chief Medical Officer at Neumora Therapeutics, Inc. Dr. Gold obtained his undergraduate, graduate, and doctorate degrees from the University of Miami.
Aktive Positionen von Michael Gold
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPASS PATHWAYS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2024 |
Ehemalige bekannte Positionen von Michael Gold
| Unternehmen | Position | Ende |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.02.2024 |
| ABBVIE INC. | Corporate Officer/Principal | 01.01.2023 |
| ALLON THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Michael Gold
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Allon Therapeutics, Inc.
 Allon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to protect against neurodegenerative conditions | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compass Pathways Plc
 Compass Pathways Plc BiotechnologyHealth Technology Develops therapies and drugs for the treatment of mental health and neurocognitive conditions | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
